Current Neuro-Oncology

Volume 21 Number 1
31 January 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 1, 31 January

Amsbaugh MJ, Mahajan A, Thall PF, McAleer MF, Paulino AC, Grosshans D, Khatua S, Ketonen L, Fontanilla H, McGovern SL.
A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
Int J Radiat Oncol Biol Phys. 2019 Jan 2;104(1):144-148∟. doi: 10.1016/j.ijrobp.2018.12.043∟. PMID: 30610915∟. Interventional study. ˍ

Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, Minniti G.
¹⁸F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma.
Ann Nucl Med. 2019 Jan 3;33(4):295-302∟. doi: 10.1007/s12149-018-01328-3∟. PMID: 30607877∟. Observational study. ˍ

Salvati M, Pesce A, Palmieri M, Floriana Brunetto GM, Santoro A, Frati A.
The Role and Real Effect of an Iterative Surgical Approach for the Management of Recurrent High-Grade Glioma: An Observational Analytic Cohort Study.
World Neurosurg. 2019 Jan 3, 2019:S1878-8750(18)32941-3∟. doi: 10.1016/j.wneu.2018.12.118∟. PMID: 30610982∟. Observational study. ˍ

Qie S, Yuan L, Shi HY, Zhang X, Li Y.
Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report.
Medicine (Baltimore). 2019 Jan 4;98(1):e13869∟. doi: 10.1097/MD.0000000000013869∟. PMID: 30608405∟. Case report. ˍ

Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W.
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
Radiother Oncol. 2019 Jan 4;132:135-141∟. doi: 10.1016/j.radonc.2018.12.019∟. PMID: 30825962∟. Interventional study. ˍ

Humbert O, Bourg V, Mondot L, Gal J, Bondiau PY, Fontaine D, Saada-Bouzid E, Paquet M, Chardin D, Almairac F, Vandenbos F, Darcourt J.
¹⁸F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Eur J Nucl Med Mol Imaging. 2019 Jan 5;46(3):558-568∟. doi: 10.1007/s00259-018-4240-8∟. PMID: 30612162∟. Interventional study. ˍ

Seano G, Nia HT, Emblem KE, Datta M, Ren J, Krishnan S, Kloepper J, Pinho M, Ho WW, Ghosh M, Askoxylakis V, Ferraro GB, Riedemann L, Gerstner ER, Batchelor TT, Wen PY, Lin NU, Grodzinsky AJ, Fukumura D, Huang P, Baish JW, Padera TP, Munn LL, Jain RK.
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium.
Nat Biomed Eng. 2019 Jan 7;3(3):230-245∟. doi: 10.1038/s41551-018-0334-7∟. PMID: 30948807∟. Laboratory investigation. ˍ

Buchmann N, Gempt J.
In Reply to Letter to the Editor Regarding "Can Early Postoperative O-(2-^18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Jan 17;123:470∟. doi: 10.1016/j.wneu.2018.12.019∟. PMID: 30660697∟. Comment. ˍ
Refers to: Fang X et al., Letter to the Editor Regarding "Can Early Postoperative O-(2-^18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?"
World Neurosurg. 2019 Feb 26;123:469∟. doi: 10.1016/j.wneu.2018.10.050∟. PMID: 30832182∟ Comment. ˍ
In turn refers to: Buchmann N et al., Can Early Postoperative O-(2-^18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?
World Neurosurg. 2018 Sep 27;121:e467-e474∟. doi: 10.1016/j.wneu.2018.09.139∟. PMID: 30267942∟. Observational study. ˍ

Biswas A, Adhikari N, Bakhshi S, Gopinathan VR, Sharma MC.
A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
Pediatr Neurosurg. 2019 Jan 22;54(1):57-65∟. doi: 10.1159/000495789∟. PMID: 30669145∟. Case report. ˍ

Miller JJ, Loebel F, Juratli TA, Tummala SS, Williams EA, Batchelor TT, Arrillaga-Romany I, Cahill DP.
Accelerated progression of IDH mutant glioma after first recurrence.
Neuro Oncol. 2019 Jan 22;21(5):669-677∟. doi: 10.1093/neuonc/noz016∟. PMID: 30668823∟. Observational study. ˍ

Napoleoni L, Cortellini A, Cannita K, Parisi A, Dal Mas A, Calvisi G, Venditti O, Baldi PL, Cocciolone V, Ricci A, Ficorella C.
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
Bioengineering (Basel). 2019 Jan 22;6(1):11∟. doi: 10.3390/bioengineering6010011∟. PMID: 30678211∟. Observational study. ˍ

Scheuermann A, Belongia M, Lawlor MW, Suchi M, Kaufman B, Vasudevaraja V, Serrano J, Snuderl M, Knipstein J.
Ganglioglioma in a Survivor of Infantile Glioblastoma.
J Pediatr Hematol Oncol. 2019 Jan 22, 2020;42(1):e56-e60∟. doi: 10.1097/MPH.0000000000001417∟. PMID: 30676438∟. Case report. ˍ

Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Bradley JA.
Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Int J Radiat Oncol Biol Phys. 2019 Jan 23; 2019;104(1):149-156∟. doi: 10.1016/j.ijrobp.2019.01.078∟. PMID: 30684665∟. Observational study. ˍ

Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C, Hsieh WY, Selcuklu SD, Ling L, Meng F, Jing X, Samoila A, Bale TA, Tsui DWY, Grommes C, Viale A, Souweidane MM, Tabar V, Brennan CW, Reiner AS, Rosenblum M, Panageas KS, DeAngelis LM, Young RJ, Berger MF, Mellinghoff IK.
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.
Nature. 2019 Jan 23;565(7741):654-658∟. doi: 10.1038/s41586-019-0882-3∟. PMID: 30675060∟. Laboratory investigation. ˍ

Chiblak S, Tang Z, Lemke D, Knoll M, Dokic I, Warta R, Moustafa M, Mier W, Brons S, Rapp C, Muschal S, Seidel P, Bendzsus M, Adeberg S, Wiestler OD, Haberkorn U, Debus J, Herold-Mende C, Wick W, Abdollahi A.
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche.
JCI Insight. 2019 Jan 24;4(2):e123837∟. doi: 10.1172/jci.insight.123837∟. PMID: 30674721∟. Laboratory investigation. ˍ

Corell A, Thurin E, Skoglund T, Farahmand D, Henriksson R, Rydenhag B, Gulati S, Bartek J Jr, Jakola AS.
Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study.
Acta Neurochir (Wien). 2019 Jan 24;161(2):333-341∟. doi: 10.1007/s00701-019-03799-3∟. PMID: 30675656∟. Observational study. ˍ

Latini F, Fahlström M, Berntsson SG, Larsson EM, Smits A, Ryttlefors M.
A novel radiological classification system for cerebral gliomas: The Brain-Grid.
PLoS One. 2019 Jan 24;14(1):e0211243∟. doi: 10.1371/journal.pone.0211243∟. PMID: 30677090∟. Observational study. ˍ

Forster MT, Baumgarten P, Gessler F, Maurer G, Senft C, Hattingen E, Seifert V, Harter PN, Franz K.
Influence of pregnancy on glioma patients.
Acta Neurochir (Wien). 2019 Jan 29;161(3):535-543∟. doi: 10.1007/s00701-019-03823-6∟. PMID: 30693372∟. Observational study. ˍ

Pozzoli G, Marei HE, Althani A, Boninsegna A, Casalbore P, Marlier LNJL, Lanzilli G, Zonfrillo M, Petrucci G, Rocca B, Navarra P, Sgambato A, Cenciarelli C.
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation.
J Cell Physiol. 2019 Jan 30;234(9):15459-15471∟. doi: 10.1002/jcp.28194∟. PMID: 30701538∟. Laboratory investigation. ˍ

Lu G, Rao M, Zhu P, Liang B, El-Nazer RT, Fonkem E, Bhattacharjee MB, Zhu JJ.
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
Front Neurol. 2019 Jan 31;10:42∟. doi: 10.3389/fneur.2019.00042∟. PMID: 30766509∟. Observational study. ˍ

Woo PYM, Ho JMK, Tse TPK, Lam SW, Mak CHK, Chan DTM, Lee MWY, Wong ST, Chan KY, Poon WS.
Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
J Clin Neurosci. 2019 Jan 31;63:134-141∟. doi: 10.1016/j.jocn.2019.01.022∟. PMID: 30712777∟. Observational study. ˍ